Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
Condition(s):Triple Negative Breast CancerLast Updated:December 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Triple Negative Breast CancerLast Updated:December 28, 2023Completed
Condition(s):Lung CancerLast Updated:March 18, 2024Active, not recruiting
Condition(s):Malignant Solid Neoplasm; Ovarian Low Grade Serous Adenocarcinoma; Pancreatic Carcinoma; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8Last Updated:March 15, 2024Recruiting
Condition(s):Melanoma; MetastasisLast Updated:January 5, 2024Recruiting
Condition(s):Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Unresectable CarcinomaLast Updated:January 10, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.